69 completed, 17 terminated, 8 unknown, 5 active not recruiting. 65 Phase 2, 18 Phase 1, 14 Phase 3, 4 Not applicable.
Follow Adenocarcinoma, Bronchiolo-Alveolar: new trials by email Literature Review of Adenocarcinoma, Bronchiolo-Alveolar trials Research Report on Adenocarcinoma, Bronchiolo-Alveolar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies Double Lung Transplantation - Lung Cancer, Bilateral Cancer | Recruiting | Northwestern University | 125 | 2022-11-16 | 2026-10-21 | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) Cancer, All Types, Cancer of Liver | Unknown | SpeciCare | 1000 | 2019-03-21 | 2020-12-04 | |
| Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer Nivolumab, Stereotactic Body Radiation Therapy - Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Neoplasm | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 140 | 2017-06-26 | 2026-06-22 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 798 | 2017-01-30 | 2026-06-17 |
| A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing Multifocal Tissue Banking - Lung Neoplasms, Carcinoma Non-small-cell Lung | Terminated | Mayo Clinic | 8 | 2016-02-11 | 2022-04-14 | |
| Telomere Biology in Early Adenocarcinoma of the Lung Adenocarcinoma of the Lung, Adenocarcinoma, Bronchiolo-Alveolar | Unknown | Meir Medical Center | 100 | 2014-09-01 | 2014-09-12 | |
| Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer Radiation Therapy, Carboplatin, Metformin - Adenosquamous Lung Carcinoma, Bronchioloalveolar Carcinoma | Phase 2 | Completed | NRG Oncology | 170 | 2014-08-01 | 2026-07-13 |
| Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer soy isoflavones, cisplatin, etoposide - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 1 | Completed | Barbara Ann Karmanos Cancer Institute | 11 | 2014-08-01 | 2020-11-23 |
| Treatment of Multifocal Lung Adenocarcinoma Multifocal Lung Adenocarcinoma - Lung Neoplasms, Carcinoma Non-small-cell Lung | Not applicable | Terminated | Mayo Clinic | 100 | 2013-11-06 | 2025-11-20 |
| Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy pazopanib hydrochloride, laboratory biomarker analysis, pharmacogenomic studies - Lung Cancer | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 102 | 2011-07-01 | 2018-07-12 |
| Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery 3-Dimensional Conformal Radiation Therapy, Carboplatin, Laboratory Biomarker Analysis - Lung Adenocarcinoma, Lung Adenocarcinoma, Mixed Subtype | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 53 | 2011-06-20 | 2026-10-20 |
| Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer panitumumab, carboplatin, paclitaxel - Lung Cancer | Phase 2 | Completed | Radiation Therapy Oncology Group | 71 | 2011-02-01 | 2022-06-15 |
| MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy Akt Inhibitor MK2206, Erlotinib Hydrochloride, Laboratory Biomarker Analysis - Adenosquamous Lung Carcinoma, Bronchioloalveolar Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 80 | 2011-02-01 | 2016-11-29 |
| Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Paclitaxel, Carboplatin, Bevacizumab - Lung Cancer | Phase 3 | Completed | ECOG-ACRIN Cancer Research Group | 1516 | 2010-10-25 | 2023-07-07 |
| Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial). bevacizumab, erlotinib, bevacizumab, pemetrexed, cisplatin - Lung Cancer | Phase 2 | Completed | Swiss Cancer Institute | 149 | 2010-06-01 | 2019-05-15 |
| Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers bevacizumab, carboplatin, erlotinib hydrochloride - Lung Cancer | Phase 2 | Completed | UNC Lineberger Comprehensive Cancer Center | 38 | 2010-03-01 | 2017-10-30 |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status hypofractionated radiation therapy - Lung Cancer | Phase 1 | Completed | University of Texas Southwestern Medical Center | 60 | 2009-10-01 | 2020-08-20 |
| Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer bevacizumab, docetaxel, gemcitabine hydrochloride - Lung Cancer | Phase 2 | Completed | Nathan Pennell, MD, PhD | 13 | 2009-09-01 | 2022-08-16 |
| Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Erlotinib plus Romidepsin (8 mg/m^2), Erlotinib plus Romidepsin (10 mg/m^2), Erlotinib plus Romidepsin (10 mg/m^2) + Antiemetic prophylaxis - Lung Cancer, Metastatic Cancer | Phase 1 | Completed | University of Texas Southwestern Medical Center | 17 | 2009-09-01 | 2021-01-20 |
| Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer carboplatin, gefitinib, paclitaxel - Lung Cancer | Phase 2 | Unknown | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 26 | 2009-05-01 | 2013-08-12 |
Showing 20 of 103. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (93) · Adenocarcinoma of Lung (85) · Lung Neoplasms (79) · Neoplasm Metastasis (5) · Small Cell Lung Carcinoma (4) · Adenocarcinoma (3) · Adenocarcinoma in Situ (2) · Bile Duct Neoplasms (2) · Brain Neoplasms (2) · Burkitt Lymphoma (2) · Carcinoma, Transitional Cell (2) · Cholangiocarcinoma (2) · Hodgkin Disease (2) · Immunoblastic Lymphadenopathy (2)
Carcinoma (103) · Neoplasms by Histologic Type (103) · Neoplasms by Site (103) · Neoplasms, Glandular and Epithelial (103) · Respiratory Tract Neoplasms (103) · Thoracic Neoplasms (103) · Neoplasms (101) · Adenocarcinoma (100) · Respiratory Tract Diseases (98) · Lung Diseases (96) · Bronchial Neoplasms (94) · Carcinoma, Bronchogenic (94) · Lung Neoplasms (24) · Adenocarcinoma of Lung (18) · Pathological Conditions, Signs and Symptoms (10)
Carboplatin (31) · Paclitaxel (26) · Radiotherapy (23) · Bevacizumab (19) · Erlotinib Hydrochloride (16) · Cisplatin (14) · Gemcitabine (12) · Docetaxel (11) · Gefitinib (11) · Pemetrexed (9) · Taxes (9) · Etoposide (5) · Cetuximab (4) · Chemotherapy, Adjuvant (4) · Neoadjuvant Therapy (4)
National Cancer Institute (NCI) (17) · Alliance for Clinical Trials in Oncology (13) · Radiation Therapy Oncology Group (5) · Wake Forest University Health Sciences (5) · ECOG-ACRIN Cancer Research Group (4) · Eastern Cooperative Oncology Group (4) · SWOG Cancer Research Network (4) · Barbara Ann Karmanos Cancer Institute (3) · Memorial Sloan Kettering Cancer Center (3) · University of Texas Southwestern Medical Center (3) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Intergroupe Francophone de Cancerologie Thoracique (2) · Mayo Clinic (2) · National Cancer Center, Korea (2) · Northwestern University (2)
United States (81) · Australia (5) · Canada (4) · France (4) · Belgium (3) · South Korea (3) · Israel (2) · Netherlands (2) · Peru (2) · Puerto Rico (2) · South Africa (2) · Switzerland (2) · United Kingdom (2) · China (1) · Egypt (1)
Antonius A. Miller, MD (4) · Arthur William Blackstock, MD (3) · Antoinette J. Wozniak, MD (2) · David P. Carbone, MD, PhD (2) · Howard L. West, MD (2) · Robert D. Timmerman, MD (2) · Suresh Ramalingam, MD (2) · Adrian Ochsenbein, MD (1) · Afshin Dowlati, MD (1) · Alan Sandler (1) · Andrew S. Kraft, MD (1) · Andrew T. Turrisi, MD (1) · Angela Davies, MD (1) · Ankit Bharat, MD (1) · Ann Mauer (1)
PMID 14688710, PMID 14731343, PMID 14998842, PMID 15254048, PMID 15301880, PMID 15821648, PMID 15893009, PMID 16055865, PMID 16785054, PMID 17167137, PMID 17264337, PMID 17374834, PMID 17406356, PMID 17509725, PMID 18096059, PMID 18355490, PMID 18487565, PMID 18757331, PMID 18827613, PMID 19251095, PMID 19349492, PMID 19574932, PMID 19581016, PMID 19632716, PMID 19833819, PMID 19933904, PMID 20035186, PMID 20035187, PMID 20035238, PMID 20233825, PMID 20347506, PMID 20593535, PMID 21247755, PMID 21422434, PMID 21555682, PMID 21747084, PMID 23009726, PMID 24100924, PMID 24928469, PMID 25074417, PMID 25922429, PMID 26381515, PMID 26774201, PMID 27032107, PMID 27993482, PMID 28359318, PMID 30442588, PMID 30602615, PMID 31361535, PMID 31969335
U10CA031946 (10), U10CA032102 (8), U10CA021115 (4), N01CM62201 (3), N01CM62209 (3), U10CA180888 (3), P30CA022453 (2), P30CA068485 (2), N01CM00038 (1), N01CM00071 (1), N01CM17102 (1), N01CM62207 (1), N01CM62208 (1), P30CA006973 (1), P30CA012197 (1)